These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38618730)

  • 1. Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma.
    Nguyen T; Chen PC; Pham J; Kaur K; Raman SS; Jewett A; Chiang J
    Crit Rev Immunol; 2024; 44(5):71-85. PubMed ID: 38618730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma.
    Zhuang L; Fulton RJ; Rettman P; Sayan AE; Coad J; Al-Shamkhani A; Khakoo SI
    Hepatol Int; 2019 Jan; 13(1):75-83. PubMed ID: 30467624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.
    Xu Y; Sun F; Tian Y; Zeng G; Lei G; Bai Z; Wang Y; Ge X; Wang J; Xiao C; Wang Z; Hu M; Song J; Yang P; Liu R
    Int Immunopharmacol; 2024 Mar; 129():111628. PubMed ID: 38320351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.
    Jacquelot N; Seillet C; Souza-Fonseca-Guimaraes F; Sacher AG; Belz GT; Ohashi PS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma.
    Nishida S; Levi DM; Tzakis AG
    Curr Opin Organ Transplant; 2013 Dec; 18(6):690-4. PubMed ID: 24220052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.
    Yu M; Li Z
    Front Med; 2017 Dec; 11(4):509-521. PubMed ID: 28780700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
    Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
    Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients.
    Mahgoub S; Abosalem H; Emara M; Kotb N; Maged A; Soror S
    Mol Immunol; 2021 Sep; 137():221-227. PubMed ID: 34284214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy.
    Chiang J; Chen PC; Pham J; Nguyen CQ; Kaur K; Raman SS; Jewett A
    Front Immunol; 2023; 14():1284669. PubMed ID: 37954598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
    Liu P; Chen L; Zhang H
    J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
    Bozward AG; Warricker F; Oo YH; Khakoo SI
    Front Immunol; 2021; 12():643310. PubMed ID: 33995362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
    Kalathil SG; Thanavala Y
    Cells; 2021 May; 10(6):. PubMed ID: 34071188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
    Sung PS; Jang JW
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking CD47 promotes antitumour immunity through CD103
    Wang S; Wu Q; Chen T; Su R; Pan C; Qian J; Huang H; Yin S; Xie H; Zhou L; Zheng S
    J Hepatol; 2022 Aug; 77(2):467-478. PubMed ID: 35367532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress on immunotherapy based on NK cells for hepatocellular carcinoma].
    Zhu X; Zhou Y; Zhu S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):80-88. PubMed ID: 38246181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review.
    Schoenberg MB; Li X; Li X; Han Y; Börner N; Koch D; Guba MO; Werner J; Bazhin AV
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108220. PubMed ID: 34673334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma.
    Li J; Li Y; Li F; Xu L
    Sci Rep; 2023 May; 13(1):7294. PubMed ID: 37147523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
    Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.